本页面由Tiger Trade Technology Pte. Ltd.提供服务

Recursion Pharmaceuticals, Inc.

4.01
-0.3502-8.03%
成交量:2,138.40万
成交额:8,661.85万
市值:21.45亿
市盈率:-3.92
高:4.37
开:4.31
低:3.91
收:4.36
52周最高:7.18
52周最低:2.77
股本:5.35亿
流通股本:5.22亿
量比:0.45
换手率:4.09%
股息:- -
股息率:- -
每股收益(TTM):-1.0219
每股收益(LYR):-1.4410
净资产收益率:-56.58%
总资产收益率:-27.33%
市净率:2.34
市盈率(LYR):-2.78

数据加载中...

2026/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/12

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/24

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/25

重要事件披露

Form 8-K - Current report
2026/03/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities